CRAIG ROUBEN: Open Payments
NPI 1043562267 · ELIZABETHTOWN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$587 in 38 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $404 · 2025 $587
Food & beverage: $587
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $276 |
| Indivior Inc. | 3 | $84 |
| Braeburn Inc. | 4 | $77 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $43 |
| Alkermes, Inc. | 1 | $34 |
| Axsome Therapeutics, Inc. | 2 | $31 |
| Gilead Sciences, Inc. | 1 | $25 |
| Lundbeck LLC | 1 | $16 |
Products named: VRAYLAR, MAVYRET, SUBLOCADE, BRIXADI, CAPLYTA, VIVITROL, Auvelity, REXULTI.
Industry payments across KY — which companies pay providers there.
